Stocks to buy

Now that the federal government is finally taking action on cannabis rescheduling — moving it to Schedule III and creating de facto medical cannabis legalization — many are wondering about the status of cannabis stocks as a whole. Cannabis stocks, as a whole, spiked upwards on the news but quickly reverted to pre-announcement norms. That’s
0 Comments
Buying stocks can lead to more wealth. Your money will work for you and push you closer toward meaningful financial goals. However, you have to invest in the right stocks to increase your chances of success. Corporations with rising revenue and profit margins look promising. These companies also need to have competitive advantages and plenty
0 Comments
Semiconductors are the bedrock for many devices and resources that we use every day. They power our computers, TVs, automobiles and other everyday items. For years, semiconductor stocks have been outperforming the stock market. But, the recent artificial intelligence (AI) boom has resulted in even more growth for the industry. Some semiconductor stocks have amassed trillion-dollar valuations
0 Comments
The U.S. economy is showing remarkable resilience despite previous concerns of a slowdown. Recent data, including the S&P Global composite PMI, revealed encouraging signs of growth, surpassing expectations and hitting a 25-month high in May. Chief economist Chris Williamson highlighted the acceleration of the U.S. economic upturn, suggesting a solid GDP gain for the second
0 Comments
Investors have been navigating a complex financial landscape marked by persistent inflation and geopolitical uncertainties. Amid this backdrop, commodity stocks to buy remain a focal point. Analysts note that commodities offer returns largely independent of stocks and bonds. As a result, this asset class helps enhance diversification and overall portfolio performance. Yet commodities have lagged
0 Comments
As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resurgence. Breakthroughs in personalized medicine and gene editing technologies are driving biotech forward. The global biotechnology market was valued at $1.0 trillion in 2022 and is
0 Comments